Last Updated:
Name Designation Appointment Date Status
Avinash Shantaram Chandvankar

Appointed as Director since May 2011

Director 25-May-2011 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Briocia Pharma (India ) Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Gopal Kupposwami Ramourti

Appointed as Director since August 2010

Director 21-Aug-2010 Current
Abhay Digambar Kapse

Appointed as Director since November 2010

Director 26-Nov-2010 Current

People Timeline

Explore the timeline of key personnel in Briocia Pharma (India ) Limited's leadership journey.

Loading...
Contact Details
  • Address 206 Shivai Industrial Estate 89, Andheri- Kurla Road, Sakinaka Andher, I [East], Mumbai Maharashtra, 400072, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 400072
  • Country India
  • Website -
Frequently Asked Questions
You can contact Briocia Pharma (India ) Limited through their registered address at 206 Shivai Industrial Estate 89, Andheri- Kurla Road, Sakinaka Andher, I [East], Mumbai Maharashtra, 400072, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Briocia Pharma (India ) Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • AVINASH SHANTARAM CHANDVANKAR
  • GOPAL KUPPOSWAMI RAMOURTI
  • ABHAY DIGAMBAR KAPSE
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available